智紡國際控股(08521.HK)中期純利619萬港元 同比增長4倍
格隆匯8月13日丨智紡國際控股(08521.HK)公吿,截至2021年6月30日止6個月,公司收益6467萬港元,同比增長53.7%;公司毛利率亦下降至27.2%(截至2020年6月30日止六個月:31.8%),此乃主要由於原材料成本上升及集團於充滿競爭的環境下提供定價更具競爭力的產品。公司擁有人應占溢利619萬港元,同比增長4倍。
董事認為,收益大幅增加乃由於中國的經濟自新型冠狀病毒疫情全球爆發後穩步復甦所致。於2020年上半年,中國政府實施的多種積極預防COVID-19措施令集團的營運及集團客户的業務營運暫停,因而導致集團收到的採購訂單大幅減少。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.